ITEM 1.
(A) NAME OF ISSUER:
Advaxis, Inc. (the Issuer)
(B) ADDRESS OF ISSUERS PRINCIPAL EXECUTIVE OFFICE:
305
College Road East, Princeton, New Jersey 08540
ITEM 2.
(A) NAME OF PERSON FILING:
Amgen Inc., a Delaware corporation
(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
Amgen Inc: One Amgen Center Drive, Thousand Oaks, California 91320-1799
(C) CITIZENSHIP:
Amgen Inc.: Delaware, U.S.A.
(D) TITLE OF CLASS OF SECURITIES:
Common Stock, $0.001 par
value
(E) CUSIP NUMBER:
007624208
ITEM 3. STATEMENT FILED PURSUANT TO RULE
13D-1(B)
OR
13D-2(B)
OR (C)
Not applicable.
ITEM 4. OWNERSHIP.
(a), (b) and (c)The information contained on the cover page to this Schedule 13G is incorporated herein by reference. The change in the percent of the
Issuers common stock outstanding previously reported by the reporting person resulted solely from a change in the aggregate number of shares of the Issuers common stock outstanding.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the
following ☒.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION
OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON
Not applicable.